With that remaining said, with no human trials there is no way to actually assess how much YK11 can inhibit Myostatin in humans (if in any way), and when there is a dosage that can equate to the exact same volume of Myostatin inhibition that a genetic anomaly by using a gene mutation has.Equally, “bro science” or peer consensus must by no means